PROGNOSIS - the German Bronchiectasis Registry: first results

F. Ringshausen (Hannover, Germany)

Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Ringshausen (Hannover, Germany). PROGNOSIS - the German Bronchiectasis Registry: first results. 4059

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Phenotyping of adult patients with bronchiectasis and Yellow-Nail-Syndrome (YNS)- data from the German and the European Bronchiectasis Registries (PROGNOSIS and EMBARC)
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019


Nontuberculous mycobacteria in patients with bronchiectasis: data from the German Bronchiectasis Registry PROGNOSIS
Source: International Congress 2019 – Complex respiratory infections in clinical practice
Year: 2019

Lung Health in Europe - RUSSIAN translation
Source:
Year: 2014


LATE-BREAKING ABSTRACT: ASSOCIATION OF SEVERE EXACERBATION WITH FEV1 DECLINE AND LOSS OF AIRWAY REVERSIBILITY IN ASTHMA
Source: International Congress 2014 – Asthma: still a heterogeneous condition!
Year: 2014


Post-Tuberculosis Bronchiectasis in India:Outcomes of the Indian EMBARC Registry
Source: International Congress 2018 – Pulmonary tuberculosis: long term complications, rehabilitation and challenges
Year: 2018


Late Breaking Abstract - Sensibility and specificity of the “SLEEP CLINICAL RECORD” Protocol  in Brazilian children.
Source: International Congress 2018 – New ideas about respiratory and sleep physiology in children
Year: 2018



Late Breaking Abstract - Validation of the REVEAL 2.0 Risk Score with the Australian and New Zealand Pulmonary Hypertension Registry Cohort.
Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension
Year: 2019



LATE-BREAKING ABSTRACT: GENDER DIFFERENCES IN ASTHMATIC CHILDREN
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013

Lung Health in Europe - GREEK translation
Source: White Book 2014
Year: 2014


The Severe Asthma Registry – German data
Source: International Congress 2018 – Physiological and biological insights in asthma
Year: 2018

Severe Paediatric Asthma Collaborative in Europe (SPACE): protocol for a European registry
Source: Breathe, 14 (2) 93; 10.1183/20734735.002018
Year: 2018



Late Breaking Abstract - CPAnet Registry – An International Chronic Pulmonary Aspergillosis Registry
Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond
Year: 2020




Eradication of Pseudomonas aeruginosa within the baseline dataset of the German Bronchiectasis Registry PROGNOSIS
Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Year: 2020


Late Breaking Abstract - Preliminary analysis of the data of patients with severe bronchial asthma included in the Russian National Register of Severe Asthma (RSAR)
Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts
Year: 2019


Prevalence and Risk Factors of Asthma and Allergy-Related Diseases among Adolescents (PERFORMANCE) study: rationale and methods
Source: ERJ Open Res, 4 (2) 00034-2018; 10.1183/23120541.00034-2018
Year: 2018



Asthma as a co-morbidity and cause of bronchiectasis: data from the European Bronchiectasis Registry (EMBARC).
Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Year: 2020


Management of bronchiectasis in Europe: Data from the European bronchiectasis registry (EMBARC)
Source: International Congress 2016 – Clinical update on bronchiectasis
Year: 2016

LATE-BREAKING ABSTRACT: GENE ENVIRONMENT INTERACTION ANALYSIS OF OBESITY AND ASTHMA
Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD
Year: 2014

Real-World Experience with dupilumab in Severe Asthma: One year data from an Italian Named Patient Program
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021